Omeros Corporation (OMER) Dividend History

Omeros Corporation is an American biopharmaceutical company focused on the discovery, development, and commercialization of drugs for areas such as inflammation, respiratory illness, and Central Nervous System disorders. It leverages its proprietary small-molecule and biologic platforms to develop therapies aimed at underserved medical needs.

201 Elliott Avenue West, Seattle, WA, 98119
Phone: 206-676-5000
Website: https://www.omeros.com

Dividend History

Omeros Corporation currently does not pay dividends

Company News

  • Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter

    The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged to a new all-time high and also recorded its best first-quarter performance in five years. For the quarter, the S&P 500 gained 10.2% to record its best first-quarter gain since 2019. The Dow Jones added 5.6% during the quarter, notching its best first-quarter performance since 2021. On the month, the S&P 500 gained 3.1%, while the Dow added 2.1%. Shares of MSC Industrial Direct Co., Inc. (NYSE: MSM) fell around 2.5% during Thursday’s session after the company reported mixed second-quarter results. Walgreens Boots Alliance Inc (NASDAQ:

    Benzinga
    Featured Companies: MSM NGS PVH WBA
  • Brian's Big Idea on Biotech

    A look at drugs for drug addiction and the biotech space.

    Zacks Investment Research
    Featured Companies: CYBN
  • Why Shares of Omeros Dropped on Monday

    The clinical-stage biopharmaceutical released trials data through a presentation.

    The Motley Fool
  • Best Penny Stocks To Buy: 5 To Watch With Big News This Week

    Penny stocks to watch with big news this week. The post Best Penny Stocks To Buy: 5 To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: SOUN
  • Omeros: Taking It To The Max

    Omeros stock has been drifting with a downward bias since Q4 2021 earnings. See how OMER's recent deal works to maintain its liquidity without shareholder dilution.

    Seeking Alpha
Page data last updated 07/23/2025 16:29:53 UTC